Keros Therapeutics (KROS) Earnings Date & Reports

A.I. Advisor

published Earnings

KROS is expected to report earnings to -125 cents per share on October 31

Keros Therapeutics KROS Stock Earnings Reports

Q3'24

Est.

$-1.26

Q2'24

Beat

by $0.01

Q1'24

Beat

by $0.12

Q4'23

Beat

by $0.03

Q3'23

Beat

by $0.02

The last earnings report on August 07 showed earnings per share of -125 cents, beating the estimate of -125 cents. With 291.00K shares outstanding, the current market capitalization sits at 2.12B.

View a ticker or compare two or three

Compare

KROS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For KROS
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for KROS (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a biopharmaceutical company, which focuses on treatments for rare muscle diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

1050 Waltham Street

Phone

+1 617 314-6297

Employees

136

Web

https://www.kerostx.com